Journal of Oncology / 2019 / Article / Tab 1

Research Article

Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy

Table 1

Patient characteristics.

Total patients31
 TACE29 (93.5)
 TAI2 (6.5)
Male sex28 (90.3)
Age at TACE or TAI, years68.5 ± 9.8 (43–84)
 A28 (90.3)
 B3 (9.7)
 C0 (0)
Previous PBT treatments
 125 (80.6)
 25 (16.1)
 30 (0)
 41 (3.2)
Diameter of HCC treated using PBT, mm37.5 ± 26.6 (8-122)
Median follow-up time after earliest PBT, days559 (34–5,383)
Median follow-up time after latest PBT, days464 (34–5,383)
Targeted HCCs in TACE or TAI
 Irradiated HCCs targeted18
 Irradiated HCCs not targeted13
PBT-related findings
 Abnormal staining of irradiated liver parenchyma22 (71.0)
 Development of tortuous tumor feeder13 (41.9)
 Development of extrahepatic collateral pathway7 (22.6)
 Development of AP/AV shunt4 (12.9)

Data are reported as number (percentage), median (range) or mean ± standard deviation.
TACE: transarterial chemoembolization, TAI: transcatheter arterial infusion, PBT: proton beam therapy, HCC: hepatocellular carcinoma, AP/AV: arterio-portal or arteriovenous.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.